Clinical Trials Browser

Phase EARLY_PHASE1 × Completed × Triple Negative Breast Neoplasms × Clear all

NCT06273852 2025-08-11

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

Phase EARLY_PHASE1 Completed

BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms

NCT03599453 2023-07-18

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Phase EARLY_PHASE1 Completed

Triple Negative Breast Neoplasms

NCT03197389 2021-05-19

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Phase EARLY_PHASE1 Completed

54 enrolled 9 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01467310 2020-09-02

Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00640861 2018-10-31

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms